MX9708537A - Quimiocina beta-8 quimiocina beta-1 y proteina-4 inflamatoria de los macrofagos, humanas. - Google Patents
Quimiocina beta-8 quimiocina beta-1 y proteina-4 inflamatoria de los macrofagos, humanas.Info
- Publication number
- MX9708537A MX9708537A MX9708537A MX9708537A MX9708537A MX 9708537 A MX9708537 A MX 9708537A MX 9708537 A MX9708537 A MX 9708537A MX 9708537 A MX9708537 A MX 9708537A MX 9708537 A MX9708537 A MX 9708537A
- Authority
- MX
- Mexico
- Prior art keywords
- disclosed
- polypeptides
- beta
- chemokine beta
- chemokine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/521—Chemokines
- C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Toxicology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Communicable Diseases (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44688195A | 1995-05-05 | 1995-05-05 | |
PCT/US1995/009058 WO1996034891A1 (en) | 1995-05-05 | 1995-06-23 | Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9708537A true MX9708537A (es) | 1998-02-28 |
Family
ID=23774170
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9708537A MX9708537A (es) | 1995-05-05 | 1995-06-23 | Quimiocina beta-8 quimiocina beta-1 y proteina-4 inflamatoria de los macrofagos, humanas. |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0871672A4 (de) |
JP (2) | JPH11505417A (de) |
KR (1) | KR19990008335A (de) |
CN (2) | CN1515672A (de) |
AU (1) | AU3134695A (de) |
CA (1) | CA2220123A1 (de) |
MX (1) | MX9708537A (de) |
WO (1) | WO1996034891A1 (de) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6488925B2 (en) | 1993-12-22 | 2002-12-03 | Human Genome Sciences, Inc. | Macrophage inflammatory protein-4 (MIP-4) polypeptides |
US6001606A (en) * | 1994-03-08 | 1999-12-14 | Human Genome Sciences, Inc. | Polynucleotides encoding myeloid progenitor inhibitory factor-1 (MPIF-1) and polypeptides encoded thereby |
US6811773B1 (en) | 1993-12-22 | 2004-11-02 | Human Genome Sciences, Inc. | Human monocyte colony inhibitory factor (M-CIF) polypeptides |
US6451562B1 (en) | 1993-12-22 | 2002-09-17 | Human Genome Sciences, Inc. | Polypeptides encoding myeloid progenitor inhibitory factor-1 (MPIF-1) polynucleotides |
US6495129B1 (en) | 1994-03-08 | 2002-12-17 | Human Genome Sciences, Inc. | Methods of inhibiting hematopoietic stem cells using human myeloid progenitor inhibitory factor-1 (MPIF-1) (Ckbeta-8/MIP-3) |
PL326080A1 (en) * | 1995-09-29 | 1998-08-17 | Smithkline Beecham Corp | Short forms of chemokin beta-8 |
US6512103B1 (en) | 1995-12-08 | 2003-01-28 | Schering Corporation | Mammalian chemokine reagents |
US7888466B2 (en) | 1996-01-11 | 2011-02-15 | Human Genome Sciences, Inc. | Human G-protein chemokine receptor HSATU68 |
ES2256885T3 (es) | 1996-04-30 | 2006-07-16 | Pharis Biotec Gmbh | Nuevas quimiocinas del tipo cc. |
CN1239510A (zh) * | 1996-09-30 | 1999-12-22 | 人类基因组科学公司 | 用髓先祖抑制因子-1、单核细胞集落抑制因子和巨噬细胞抑制因子-4治疗疾病的组合物和方法 |
US5912327A (en) * | 1996-09-30 | 1999-06-15 | Human Genome Sciences, Inc. | Method of purifying chemokines from inclusion bodies |
US6632425B1 (en) | 1997-03-20 | 2003-10-14 | Human Genome Sciences, Inc. | Chemokine compositions |
CA2291221A1 (en) | 1997-05-30 | 1998-12-03 | Human Genome Sciences, Inc. | 32 human secreted proteins |
KR20010031713A (ko) | 1997-11-03 | 2001-04-16 | 벤슨 로버트 에이치. | 맥관형성 및 종양 성장 억제제인 맥관 내피 세포 성장억제제 |
KR19990042713A (ko) * | 1997-11-27 | 1999-06-15 | 허일섭 | 사람에서 분리한 c 6 베타-케모카인 lkn-1의 cdna 및 재조합 lkn-1의 제조방법 |
EP1093457B8 (de) | 1998-03-19 | 2011-02-02 | Human Genome Sciences, Inc. | Der gemeinsamen gamma-kette ähnlicher zytokinrezeptor |
WO2000001817A2 (en) * | 1998-07-06 | 2000-01-13 | Schering Corporation | Mammalian genes; dendritic cell prostaglandin-like transponder (dc-pgt), hdtea84, hsljd37r and rankl, hcc5 chemokine, deubiquitinating 11 and 12 (dub11, dub12), md-1, md2 and cyclin e2, related reagents and methods |
EP0974357A1 (de) | 1998-07-16 | 2000-01-26 | Schering-Plough | Chemokine als Adjuvantien der Immunantwort |
AU1716300A (en) | 1998-11-10 | 2000-05-29 | Beatson Institute For Cancer Research | Chemokine beta-7 |
JP2003516934A (ja) * | 1999-10-14 | 2003-05-20 | ヒューマン ジノーム サイエンシーズ, インコーポレイテッド | ヒト骨髄前駆細胞阻害性因子−1(mpif−1)を用いる、細胞、組織および器官の損傷を処置または予防する方法 |
EP1167527A1 (de) * | 2000-06-22 | 2002-01-02 | Euroscreen S.A. | Prozessierte Menschliche Chemokine: PHC-1 und PHC-2 |
JP2003512843A (ja) * | 1999-10-25 | 2003-04-08 | オーロスクレーン エス. エー. | 処理されたヒトケモカインのphc−1とphc−2 |
AU2001259063A1 (en) | 2000-04-12 | 2001-10-30 | Human Genome Sciences, Inc. | Albumin fusion proteins |
AU2001282856A1 (en) | 2000-06-15 | 2001-12-24 | Human Genome Sciences, Inc. | Human tumor necrosis factor delta and epsilon |
EP1176200A3 (de) | 2000-06-20 | 2005-01-12 | Switch Biotech Aktiengesellschaft | Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren zur Diagnose oder Behandlung von Hauterkrankung oder Wundheilung sowie ihre Verwendung zur Indentifizierung von pharmakologisch aktiven Substanzen |
AU2001271621A1 (en) | 2000-06-28 | 2002-01-08 | Diadexus, Inc. | Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
IL154596A0 (en) | 2000-08-25 | 2003-09-17 | Basf Plant Science Gmbh | Plant polynucleotides encoding novel prenyl proteases |
US6989247B2 (en) | 2000-11-28 | 2006-01-24 | Celltech R & D, Inc. | Compositions and methods for diagnosing or treating psoriasis |
DE602004021419D1 (de) * | 2003-12-05 | 2009-07-16 | Oxagen Ltd | Die aktivität von ccrl2 modulierende mittel und verfahren zu deren anwendung |
US7572618B2 (en) | 2006-06-30 | 2009-08-11 | Bristol-Myers Squibb Company | Polynucleotides encoding novel PCSK9 variants |
JP5256199B2 (ja) | 2006-08-07 | 2013-08-07 | テヴァ バイオファーマシューティカルズ ユーエスエー,インコーポレーティッド | アルブミン−インスリン融合タンパク質 |
ES2676878T3 (es) | 2011-03-03 | 2018-07-25 | Zymeworks Inc. | Diseño de armazón de heteromultímero multivalente y constructos |
WO2014012082A2 (en) | 2012-07-13 | 2014-01-16 | Zymeworks Inc. | Multivalent heteromultimer scaffold design an constructs |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0795952B2 (ja) * | 1986-01-08 | 1995-10-18 | カルジ−ン・インコ−ポレイテツド | ハロアリ−ルニトリル分解遺伝子、その使用および該遺伝子含有細胞 |
ATE177472T1 (de) * | 1990-09-14 | 1999-03-15 | Chiron Corp | Expression von makrophagen-induzierbaren proteinen (mips) in hefezellen |
EP0735818B1 (de) * | 1993-12-22 | 2004-03-31 | Human Genome Sciences, Inc. | ENTZÜNDUNGSPROTEINE AUS MAKROPHAGEN MIP-3, MIP-4 UND MIP-1Gamma |
ES2177625T3 (es) * | 1993-12-24 | 2002-12-16 | Wolf-Georg Forssmann | Citoquina cc-1 humana circulante. |
US5602008A (en) * | 1994-11-29 | 1997-02-11 | Incyte Pharmaceuticals, Inc. | DNA encoding a liver expressed chemokine |
US5874211A (en) * | 1995-04-13 | 1999-02-23 | Incyte Pharmaceuticals, Inc. | Chemokine expressed in eosinophils |
-
1995
- 1995-06-23 CN CNA021471495A patent/CN1515672A/zh active Pending
- 1995-06-23 EP EP95927260A patent/EP0871672A4/de not_active Withdrawn
- 1995-06-23 CN CN95197892A patent/CN1125082C/zh not_active Expired - Fee Related
- 1995-06-23 JP JP8533269A patent/JPH11505417A/ja not_active Ceased
- 1995-06-23 KR KR1019970707861A patent/KR19990008335A/ko not_active Application Discontinuation
- 1995-06-23 AU AU31346/95A patent/AU3134695A/en not_active Abandoned
- 1995-06-23 CA CA002220123A patent/CA2220123A1/en not_active Abandoned
- 1995-06-23 MX MX9708537A patent/MX9708537A/es unknown
- 1995-06-23 WO PCT/US1995/009058 patent/WO1996034891A1/en not_active Application Discontinuation
-
2002
- 2002-06-21 JP JP2002181851A patent/JP2003102486A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CN1125082C (zh) | 2003-10-22 |
CN1186501A (zh) | 1998-07-01 |
WO1996034891A1 (en) | 1996-11-07 |
CA2220123A1 (en) | 1996-11-07 |
CN1515672A (zh) | 2004-07-28 |
JPH11505417A (ja) | 1999-05-21 |
EP0871672A4 (de) | 1999-05-12 |
KR19990008335A (ko) | 1999-01-25 |
EP0871672A1 (de) | 1998-10-21 |
JP2003102486A (ja) | 2003-04-08 |
AU3134695A (en) | 1996-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9708537A (es) | Quimiocina beta-8 quimiocina beta-1 y proteina-4 inflamatoria de los macrofagos, humanas. | |
DE69433648D1 (de) | Menschliche chemokin-polypeptide | |
DE69533627D1 (en) | Humanes chemokin beta-13 | |
MX9701330A (es) | Quimiocina beta-9 humana. | |
WO1997035010A8 (en) | Chemokine alpha 2 | |
EP0814158A3 (de) | Abweichende Form des menschlichen C3a Rezeptor; diagnostzische und therapeutische Verwendungen | |
NZ271756A (en) | Human macrophage inflammatory proteins and coding sequences, their production and use | |
EP0792370A4 (de) | APOPTOSE-PROTEASEN 3 UND 4, ÄHNLICH DEN UMWANDLUNGSENZYM FÜR INTERLEUKIN-1-g(b) | |
AU1724795A (en) | Human tissue inhibitor of metalloproteinase-4 | |
DE69841140D1 (de) | Interleukin-17 rezeptor-ähnliches protein | |
IL85411A0 (en) | Methods and deoxyribonucleic acid for the preparation of tissue factor protein | |
KR920000789A (ko) | 면역글로불린 부분을 갖는 융합 단백질, 이의 제조방법 및 용도 | |
ATE366316T1 (de) | Monoklonale und chimäre antikörper spezifisch für menschlichen tumornekrosefaktor | |
DE69433747D1 (de) | Calcitoninrezeptor | |
AU2881389A (en) | Human ifn-beta 2/il-6, its purification and use | |
DE69230136T2 (de) | Cytokin-induziertes protein, tsg-6, seine dna und verwendung | |
ATE306549T1 (de) | C-c ckr-1, ein c-c chemokin rezeptor | |
EP0812913A3 (de) | HR1 Rezeptor, ein Rezeptor der Zytokinrezeptor-Familie | |
FI964227A0 (fi) | Hepariinia sitova proteiini verenmyrkytyksen hoitoon ja menetelmät sen valmistamiseksi | |
MX9709090A (es) | Quimiocina beta-11 humana y quimiocina alfa-1 humana. | |
FR2653445B1 (fr) | Fragment d'adnc codant pour le gene du recepteur de l'interferon alpha et procede de preparation d'une proteine correspondante. |